Portfolio Update

RNS Number : 5561L

Intl. Biotechnology Trust PLC

19 July 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 30 June 2017

Net Assets	£240m
Net Assets per share	638p
Share price	601p
Total value of unquoted investments	£22m
Total number of portfolio companies	91
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Regeneron	7.6
Celgene	7.4
Vertex	5.6
Biogen	5.3
Genmab	5.3
Alexion	3.8
Biomarin	3.5
Incyte	3.1
Amgen	2.8
Gilead	2.8
	-----------
Total	47.2

Geographical Allocation	% NAV
US & Canada	83
Europe & UK	17
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	53
Mid Cap =USD1-10BN	24
Small Cap <USD1BN	23
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	35
Orphan	14
Ophthalmology	10
CNS	8
Inflammation	7
Medtech	2
Other	24
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

19 JULY 2017

 

END

 

 

PFUBLGDRXGBBGRC